Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Free Report) shares crossed above its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $1.89 and traded as high as $2.1150. Mayne Pharma Group shares last traded at $2.1150, with a volume of 1,000 shares changing hands.
Mayne Pharma Group Stock Up 13.1%
The firm’s fifty day moving average is $2.05 and its two-hundred day moving average is $1.89.
About Mayne Pharma Group
Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company that develops, manufactures, and commercializes branded and generic prescription medicines. Its activities include product development, regulatory support, manufacturing, and the distribution of pharmaceutical products through its own commercial operations and external partners.
The company has focused on therapeutic areas including dermatology, women’s health, and other specialty-care markets. Its portfolio has included prescription products such as oral and topical medicines, as well as contraceptive and other branded therapies.
Further Reading
- Five stocks we like better than Mayne Pharma Group
- Q3 Earnings Have Investors Wondering: Is Mercado Libre Finally a Buy?
- CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?
- Array and Shoals Are Merging: Who Really Wins the All-Stock Solar Deal?
- Duolingo’s User Growth Is Outpacing Bookings, But Is Its Strategy Paying Off?
Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
